A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells†
Abstract
Herein, we report the preparation of genetically engineered
* Corresponding authors
a
Department of Advanced Medical Initiatives, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
E-mail:
m-murata@dem.med.kyushu-u.ac.jp
Fax: +81-92-642-6252
Tel: +81-92-642-6251
b Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institutes, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
c Innovation Center for Medical Redox Navigation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
d Center for Advanced Medical Innovation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Herein, we report the preparation of genetically engineered
R. Toita, M. Murata, K. Abe, S. Narahara, J. S. Piao, J. Kang and M. Hashizume, Chem. Commun., 2013, 49, 7442 DOI: 10.1039/C3CC44508A
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content